0001209191-23-006297.txt : 20230202 0001209191-23-006297.hdr.sgml : 20230202 20230202173924 ACCESSION NUMBER: 0001209191-23-006297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20230202 DATE AS OF CHANGE: 20230202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peetz Christopher CENTRAL INDEX KEY: 0001614740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 23582501 MAIL ADDRESS: STREET 1: C/O TOBIRA THERAPEUTICS, INC. STREET 2: 701 GATEWAY BOULEVARD, #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-31 0 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001614740 Peetz Christopher C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 1 1 0 0 President and CEO Common Stock 2023-01-31 4 A 0 50000 0.00 A 119576 D Common Stock 201570 I By The Peetz Family Trust Stock Option (right to buy) 23.48 2023-01-31 4 A 0 200000 0.00 A 2033-01-30 Common Stock 200000 200000 D Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan. 1/4th of the shares vest one year after January 31, 2023 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. /s/ Jody Howe, Attorney-in-Fact 2023-02-02